Jefferies Financial Group Weighs in on UnitedHealth Group Incorporated’s Q1 2023 Earnings (NYSE:UNH)

UnitedHealth Group Incorporated (NYSE:UNHGet Rating) – Investment analysts at Jefferies Financial Group upped their Q1 2023 earnings per share (EPS) estimates for shares of UnitedHealth Group in a research note issued on Tuesday, January 17th. Jefferies Financial Group analyst D. Windley now forecasts that the healthcare conglomerate will post earnings per share of $6.03 for the quarter, up from their previous forecast of $5.94. The consensus estimate for UnitedHealth Group’s current full-year earnings is $24.82 per share. Jefferies Financial Group also issued estimates for UnitedHealth Group’s Q3 2023 earnings at $6.55 EPS, Q4 2023 earnings at $6.16 EPS and FY2023 earnings at $25.12 EPS.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, topping the consensus estimate of $5.17 by $0.17. The company had revenue of $82.79 billion during the quarter, compared to analyst estimates of $82.53 billion. UnitedHealth Group had a return on equity of 27.04% and a net margin of 6.21%. The firm’s revenue was up 12.3% on a year-over-year basis. During the same quarter last year, the business posted $4.48 earnings per share.

UNH has been the topic of several other research reports. UBS Group reduced their target price on shares of UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating on the stock in a research note on Wednesday. Raymond James lowered UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 price target on the stock. in a research note on Monday, November 21st. Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $569.00 to $615.00 and gave the company a “buy” rating in a research report on Tuesday, October 18th. Loop Capital increased their target price on shares of UnitedHealth Group from $575.00 to $590.00 in a research report on Tuesday. Finally, Royal Bank of Canada upped their price objective on shares of UnitedHealth Group from $588.00 to $592.00 and gave the company an “outperform” rating in a report on Monday, October 17th. Three research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $599.28.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $484.36 on Wednesday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.82 and a current ratio of 0.77. The stock’s fifty day moving average is $519.94 and its 200 day moving average is $524.48. The firm has a market capitalization of $452.56 billion, a PE ratio of 22.86, a PEG ratio of 1.35 and a beta of 0.73. UnitedHealth Group has a fifty-two week low of $445.73 and a fifty-two week high of $558.10.

Institutional Trading of UnitedHealth Group

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Wealthstream Advisors Inc. boosted its holdings in UnitedHealth Group by 4.4% during the 2nd quarter. Wealthstream Advisors Inc. now owns 452 shares of the healthcare conglomerate’s stock valued at $232,000 after acquiring an additional 19 shares during the period. CoreCap Advisors LLC boosted its stake in shares of UnitedHealth Group by 0.5% in the 2nd quarter. CoreCap Advisors LLC now owns 4,217 shares of the healthcare conglomerate’s stock valued at $2,166,000 after buying an additional 19 shares during the period. Elgethun Capital Management raised its position in shares of UnitedHealth Group by 0.3% during the 2nd quarter. Elgethun Capital Management now owns 6,577 shares of the healthcare conglomerate’s stock worth $3,369,000 after acquiring an additional 19 shares in the last quarter. Hollencrest Capital Management raised its position in shares of UnitedHealth Group by 0.8% during the 3rd quarter. Hollencrest Capital Management now owns 2,337 shares of the healthcare conglomerate’s stock worth $1,180,000 after acquiring an additional 19 shares in the last quarter. Finally, Smith Salley & Associates raised its position in shares of UnitedHealth Group by 0.7% during the 3rd quarter. Smith Salley & Associates now owns 2,873 shares of the healthcare conglomerate’s stock worth $1,451,000 after acquiring an additional 19 shares in the last quarter. 86.31% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Erin Mcsweeney sold 616 shares of the stock in a transaction that occurred on Friday, December 2nd. The stock was sold at an average price of $535.00, for a total transaction of $329,560.00. Following the transaction, the executive vice president now owns 8,463 shares in the company, valued at approximately $4,527,705. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.40% of the company’s stock.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 13th. Stockholders of record on Monday, December 5th were given a dividend of $1.65 per share. The ex-dividend date of this dividend was Friday, December 2nd. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.36%. UnitedHealth Group’s dividend payout ratio (DPR) is 31.15%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.